Arm Limited Patent Portfolio Statistics

Arm Limited

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Arm Limited look like?

Total Applications: 3,056
Granted Patents: 2,494
Grant Index 92.61 %
Abandoned/Rejected Applications: 199 (7.39%)
In-Process Applications: 352
Average Grant Time: 2.86 Years
Average Office Actions: 1.47

Which Technology Area Arm Limited is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
2183 Computer Architecture and I/O 336
2182 Computer Architecture and I/O 164
2824 Semiconductors/Memory 101
2181 Computer Architecture and I/O 100
2827 Semiconductors/Memory 96

How many patents are Arm Limited filing every year?

Year Total Applications
2022 0*
2021 59*
2020 296
2019 362
2018 347

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Arm Limited in USPTO?

Publication number:
Application number: 17/285,397


Publication date:
Applicant: Arm Limited
Inventors: Takebe Takanori

Publication number: US20220023201A1
Application number: 17/495,548

This invention relates to a dilute, ready-to-use solution of phenylephrine hydrochloride having improved stability and utility. In a particular embodiment, the formulation consists of an injectable form of phenylephrine hydrochloride with edetate disodium chelating agent in place of any sodium metabisulfite antioxidants to improve the solution's ability to remain stable and active in a dilute state after prolonged storage. This invention also relates to a form for injection of the solution that includes packaging the solution in a single-use container, as well as a form for containing the ready-to-use solution in a sterile, sealed container. Lastly this invention relates to methods of making the injectable solution for use in a single-use container, as well as for containment in a sterile, sealed container.

Publication date: 2022-01-27
Applicant: Arm Limited
Inventors: G Michael Parker

Publication number: US20220016094A1
Application number: 17/491,330

A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Publication date: 2022-01-20
Applicant: Arm Limited
Inventors: Michael Myers

How are Arm Limited’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/285,397 Nutrition Composition Application Undergoing Preexam Processing
17/495,548 Phenylephrine Hydrochloride Ready-To-Use Solution OPAP Central, Docket
17/491,330 Sustained Release Aminopyridine Composition 1627
17/295,225 Ox40 Antibody, Preparation Method Thereof And Use Thereof Docketed New Case – Ready for Examination OPAP Central, Docket
17/480,424 Enzyme Inhibitors Docketed New Case – Ready for Examination OPAP Central, Docket